Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Marder

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Cancer|March 15, 1991
Measuring the quality of care for the cancer patientR J Marder
QRB. Quality Review Bulletin|February 1, 1990
Relationship of clinical indicators and practice guidelinesR J Marder
Cancer|July 1, 1989
Joint Commission plans for clinical indicator development for oncologyR J Marder
Journal (American Medical Record Association)|April 9, 1989
In search of ... quality. Part III. Interview by Ann E. BucklandR J Marder, B Fuchs
American Journal of Clinical Pathology|August 1, 1988
Heterogeneity of phenotypic expression in normal and neoplastic B-cell proliferations detected by monoclonal antibodies LN-1 and DLC-48R J Marder, J Winter, A Epstein
Quality Management in Health Care|May 27, 1999
Enhancing clinical pathway placementH Hassaballa, J Payne, S McFolling, et al.
The American Journal of Medicine|October 1, 1976
C1q deficiency associated with urticarial-like lesions and cutaneous vasculitisR J Marder, R Rent, E Y Choi, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 1, 1985
Immunohistochemical analysis of human lymphomas with monoclonal antibodies to B cell and Ia antigens reactive in paraffin sectionsR J Marder, D Variakojis, J Silver, et al.
Cancer|March 15, 1988
Heterogeneity among the non-Hodgkin's lymphomas. Implications for autologous bone marrow transplantation with in vitro purging using monoclonal antibodiesJ N Winter, R J Marder, B Mankad, et al.
Leukemia Research|January 1, 1989
The elimination of malignant B lymphocytes from human bone marrow using monoclonal antibodies DLC-48 and LN-1 and human serum: a preclinical studyJ N Winter, A L Epstein, B Bass, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Cancer|March 15, 1991
Measuring the quality of care for the cancer patientR J Marder
QRB. Quality Review Bulletin|February 1, 1990
Relationship of clinical indicators and practice guidelinesR J Marder
Cancer|July 1, 1989
Joint Commission plans for clinical indicator development for oncologyR J Marder
Journal (American Medical Record Association)|April 9, 1989
In search of ... quality. Part III. Interview by Ann E. BucklandR J Marder, B Fuchs
American Journal of Clinical Pathology|August 1, 1988
Heterogeneity of phenotypic expression in normal and neoplastic B-cell proliferations detected by monoclonal antibodies LN-1 and DLC-48R J Marder, J Winter, A Epstein
Quality Management in Health Care|May 27, 1999
Enhancing clinical pathway placementH Hassaballa, J Payne, S McFolling, et al.
The American Journal of Medicine|October 1, 1976
C1q deficiency associated with urticarial-like lesions and cutaneous vasculitisR J Marder, R Rent, E Y Choi, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 1, 1985
Immunohistochemical analysis of human lymphomas with monoclonal antibodies to B cell and Ia antigens reactive in paraffin sectionsR J Marder, D Variakojis, J Silver, et al.
Cancer|March 15, 1988
Heterogeneity among the non-Hodgkin's lymphomas. Implications for autologous bone marrow transplantation with in vitro purging using monoclonal antibodiesJ N Winter, R J Marder, B Mankad, et al.
Leukemia Research|January 1, 1989
The elimination of malignant B lymphocytes from human bone marrow using monoclonal antibodies DLC-48 and LN-1 and human serum: a preclinical studyJ N Winter, A L Epstein, B Bass, et al.
Pageof 4